To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 1993

Primary Completion Date

September 30, 1993

Study Completion Date

September 30, 1993

Conditions

Inflammation

Interventions

DRUG

Diclofenac Sodium 50 mg Tablets Under Fasting Conditions (Geneva Pharmaceuticals, Inc)

DRUG

Diclofenac Sodium 50 mg Tablets Under Fed Conditions (Geneva Pharmaceuticals, Inc)

DRUG

Voltaren 50 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)